Risk stratification for ventricular arrhythmia in patients with repaired tetralogy of Fallot (TOF) via image-based computational simulations
US11278247B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Nov 6, 2017 |
| Grant date | Mar 22, 2022 |
| Priority date | — |
| Expiry date | Aug 30, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61B2576/023
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
An embodiment in accordance with the present invention provides a non-invasive solution to risk stratify the risk of in arrhythmia in patients with TOF. Currently, no reliable method for non-invasive risk stratification exists. In the realm of congenital heart disease, cardiac MRI is now used routinely for patients with Tetralogy of Fallot (TOF), the most common form of cyanotic congenital heart disease. An innovative platform for using clinical MRI data to create 3D electromechanical models of the heart enables predictions of whether or not patients with ischemic heart disease have the substrate for arrhythmia and what their relative risk for such an event is. An embodiment of the current invention provides a non-invasive solution to risk stratify the risk of arrhythmia in patients with TOF. Currently, no reliable method for non-invasive risk stratification exists.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.